Medium materiality4/10
Vera Therapeutics price target raised to $43 from $35 at Wedbush
Why it may matterVerify against the original reporting
Upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush raises VERA target to $43 from $35; current price $42.96. Upside appears modest, but supports bullish sentiment.
- Wedbush raises VERA target to $43 from $35; price $42.96.
- VERA target up to $43; current price near $43.
Key facts
- 01
Target: $43
- 02
Posted price: $42.96
- 03
Analyst firm: Wedbush
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.